{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:51:56Z","timestamp":1792547516480,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,26]],"date-time":"2027-06-26T00:00:00Z","timestamp":1813968000000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017618","name":"National Institute of Diabetes and Digestive and Kidney Diseases Division of Diabetes Endocrinology and Metabolic Diseases","doi-asserted-by":"publisher","award":["T32DK007028"],"award-info":[{"award-number":["T32DK007028"]}],"id":[{"id":"10.13039\/100017618","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.eprac.2025.12.022","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:54:08Z","timestamp":1767110048000},"page":"1091-1099","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Multiple Endocrine Neoplasia Type 5 due to Germline MAX Mutations: A Systematic Review of Tumor Spectrum and Clinical Features"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6501-6180","authenticated-orcid":false,"given":"Nipith","family":"Charoenngam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natapong","family":"Thaneerat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pornlada","family":"Likasitwatanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chalermkiat","family":"Kansuttiviwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mannstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.eprac.2025.12.022_bib1","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-11-3891","article-title":"MAX and MYC: a heritable breakup","volume":"72","author":"Casc\u00f3n","year":"2012","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.eprac.2025.12.022_bib2","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","author":"Comino-M\u00e9ndez","year":"2011","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.eprac.2025.12.022_bib3","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.eprac.2025.12.022_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0092-8674(02)01284-9","article-title":"X-Ray structures of Myc-Max and Mad-Max recognizing DNA: molecular bases of regulation by proto-oncogenic transcription factors","volume":"112","author":"Nair","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.eprac.2025.12.022_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.cellbio.16.1.653","article-title":"The Myc\/Max\/Mad network and the transcriptional control of cell behavior","volume":"16","author":"Grandori","year":"2000","journal-title":"Annu Rev Cell Develop Biol"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.022_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ccell.2020.04.016","article-title":"MAX functions as a tumor suppressor and rewires metabolism in small cell lung cancer","volume":"38","author":"Augert","year":"2020","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.eprac.2025.12.022_bib7","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/MCB.15.7.3470","article-title":"The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max","volume":"15","author":"Hopewell","year":"1995","journal-title":"Mol Cell Biol"},{"issue":"9","key":"10.1016\/j.eprac.2025.12.022_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/jamaoncol.2017.0223","article-title":"Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention","volume":"3","author":"Bausch","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eprac.2025.12.022_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.574662","article-title":"Genetic and clinical profiles of pheochromocytoma and paraganglioma: a single Center study","volume":"11","author":"Ma","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"10.1016\/j.eprac.2025.12.022_bib10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ejendo\/lvaf191","article-title":"Estimated global prevalence of genetic carriers of hereditary pheochromocytoma-paraganglioma syndrome in a large multiethnic genomic database","volume":"193","author":"Charoenngam","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2025.12.022_bib11","doi-asserted-by":"crossref","first-page":"e1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.12.022_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1442691","article-title":"Genotype and clinical phenotype characteristics of MAX germline mutation-associated pheochromocytoma\/paraganglioma syndrome","volume":"15","author":"Lian","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"D1","key":"10.1016\/j.eprac.2025.12.022_bib13","doi-asserted-by":"crossref","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","article-title":"ClinVar: improving access to variant interpretations and supporting evidence","volume":"46","author":"Landrum","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.022_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ajhg.2023.11.010","article-title":"A recurrent de novo MAX p.Arg60Gln variant causes a syndromic overgrowth disorder through differential expression of c-Myc target genes","volume":"111","author":"Harris","year":"2024","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.022_bib15","article-title":"Primary hyperparathyroidism in a patient with bilateral pheochromocytoma and a mutation in the tumor suppressor MAX","volume":"1","author":"Charoenngam","year":"2023","journal-title":"JCEM Case Rep"},{"issue":"4","key":"10.1016\/j.eprac.2025.12.022_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1507\/endocrj.EJ24-0584","article-title":"Clinicopathological and genomic analysis of pediatric pheochromocytoma and sympathetic paraganglioma","volume":"72","author":"Kimura","year":"2025","journal-title":"Endocr J"},{"key":"10.1016\/j.eprac.2025.12.022_bib17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3389\/fendo.2020.00558","article-title":"A novel phenotype of germline pathogenic variants in MAX: concurrence of pheochromocytoma and ganglioneuroma in a Chinese family and literature review","volume":"11","author":"Chang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.eprac.2025.12.022_bib18","article-title":"Early-onset sarcoma with germline MAX variant: expanding the spectrum in hereditary pheochromocytoma and paraganglioma","volume":"3","author":"Eren","year":"2025","journal-title":"JCEM Case Rep"},{"key":"10.1016\/j.eprac.2025.12.022_bib19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s12020-025-04186-y","article-title":"Expanding the phenotype of multiple endocrine neoplasia type 5 (MEN5): pituitary gigantism, myelolipoma and familial pheochromocytoma due to a germline pathogenic MAX variant","volume":"88","author":"Haider","year":"2025","journal-title":"Endocrine"},{"issue":"11","key":"10.1016\/j.eprac.2025.12.022_bib20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1055\/a-1186-0790","article-title":"Pancreatic neuroendocrine neoplasm associated with a familial MAX deletion","volume":"52","author":"Petignot","year":"2020","journal-title":"Horm Metab Res"},{"issue":"2","key":"10.1016\/j.eprac.2025.12.022_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2015-2592","article-title":"Complex MAX rearrangement in a family with malignant pheochromocytoma, renal oncocytoma, and erythrocytosis","volume":"101","author":"Korpershoek","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2025.12.022_bib22","doi-asserted-by":"crossref","first-page":"L37","DOI":"10.1530\/ERC-18-0065","article-title":"Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions","volume":"25","author":"Daly","year":"2018","journal-title":"Endocrine-Related Cancer"},{"issue":"6","key":"10.1016\/j.eprac.2025.12.022_bib23","first-page":"e453","article-title":"Case report of bilateral pheochromocytomas due to a novel max mutation in a patient known to have a pituitary prolactinoma","volume":"4","author":"Kobza","year":"2018","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.eprac.2025.12.022_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.683492","article-title":"Familial acromegaly and bilateral asynchronous pheochromocytomas in a female patient with a MAX mutation: a case report","volume":"12","author":"Mamedova","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.eprac.2025.12.022_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11102-025-01607-z","article-title":"Loss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5)","volume":"28","author":"Delemer","year":"2025","journal-title":"Pituitary"},{"issue":"10","key":"10.1016\/j.eprac.2025.12.022_bib26","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1530\/ERC-22-0157","article-title":"Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours","volume":"29","author":"Loughrey","year":"2022","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"10.1016\/j.eprac.2025.12.022_bib27","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1210\/jc.2017-00562","article-title":"Clinical and molecular features of renal and pheochromocytoma\/Paraganglioma Tumor Association Syndrome (RAPTAS): case series and literature review","volume":"102","author":"Casey","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.eprac.2025.12.022_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adt3177","article-title":"MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues","volume":"11","author":"Freie","year":"2025","journal-title":"Sci Adv"},{"issue":"10","key":"10.1016\/j.eprac.2025.12.022_bib29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1530\/EC-20-0460","article-title":"Genetic predisposition to neural crest-derived tumors: revisiting the role of KIF1B","volume":"9","author":"Cardot Bauters","year":"2020","journal-title":"Endocr Connect"},{"key":"10.1016\/j.eprac.2025.12.022_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.609263","article-title":"Case report: pheochromocytoma and synchronous neuroblastoma in a family with hereditary pheochromocytoma associated with a MAX deleterious variant","volume":"12","author":"Duarte","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.eprac.2025.12.022_bib31","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab085","article-title":"A novel, likely pathogenic MAX germline variant in a patient with unilateral pheochromocytoma","volume":"5","author":"Lam-Chung","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.eprac.2025.12.022_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.cancergen.2021.01.004","article-title":"Clinical description & molecular modeling of novel MAX pathogenic variant causing pheochromocytoma in family, supports paternal parent-of-origin effect","volume":"252-253","author":"Richter","year":"2021","journal-title":"Cancer Genet"},{"key":"10.1016\/j.eprac.2025.12.022_bib33","article-title":"A novel pathogenic variant in MAX-associated pheochromocytoma","volume":"22","author":"Steinman","year":"2021","journal-title":"J Clin Translational Endocrinol Case Rep"},{"issue":"4","key":"10.1016\/j.eprac.2025.12.022_bib34","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1210\/jc.2017-02324","article-title":"18F-FDOPA PET\/CT imaging of MAX-related pheochromocytoma","volume":"103","author":"Ta\u00efeb","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.eprac.2025.12.022_bib35","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1530\/EC-21-0455","article-title":"Metastatic cluster 2-related pheochromocytoma\/paraganglioma: a single-center experience and systematic review","volume":"10","author":"Kumar","year":"2021","journal-title":"Endocr Connect"},{"issue":"11","key":"10.1016\/j.eprac.2025.12.022_bib36","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/js.2017-00135","article-title":"Case report of a prolactinoma in a patient with a novel MAX mutation and bilateral pheochromocytomas","volume":"1","author":"Roszko","year":"2017","journal-title":"J Endocr Soc"},{"issue":"4","key":"10.1016\/j.eprac.2025.12.022_bib37","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11684-018-0650-z","article-title":"The MYC transcription factor network: balancing metabolism, proliferation and oncogenesis","volume":"12","author":"Carroll","year":"2018","journal-title":"Front Med"},{"issue":"17-18","key":"10.1016\/j.eprac.2025.12.022_bib38","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1101\/gad.325878.119","article-title":"Max deletion destabilizes MYC protein and abrogates E\u03bc-Myc lymphomagenesis","volume":"33","author":"Mathsyaraja","year":"2019","journal-title":"Genes Dev"},{"issue":"6","key":"10.1016\/j.eprac.2025.12.022_bib39","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society Clinical Practice Guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"The J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2025.12.022_bib40","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12022-022-09709-1","article-title":"Overview of the 2022 WHO classification of parathyroid tumors","volume":"33","author":"Erickson","year":"2022","journal-title":"Endocr Pathol"},{"issue":"4","key":"10.1016\/j.eprac.2025.12.022_bib41","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/cen.14706","article-title":"Molecular genetic testing in the management of pituitary disease","volume":"97","author":"Coopmans","year":"2022","journal-title":"Clin Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2025.12.022_bib42","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/EJE-20-0054","article-title":"Germinal defects of SDHx genes in patients with isolated pituitary adenoma","volume":"183","author":"Mougel","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"16","key":"10.1016\/j.eprac.2025.12.022_bib43","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1158\/1078-0432.CCR-24-4354","article-title":"Update on tumor surveillance for children with hereditary pheochromocytoma\/paraganglioma syndromes","volume":"31","author":"Rednam","year":"2025","journal-title":"Clin Cancer Res"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25013515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25013515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:48:48Z","timestamp":1782467328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25013515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1530891X25013515"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.12.022","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple Endocrine Neoplasia Type 5 due to Germline MAX Mutations: A Systematic Review of Tumor Spectrum and Clinical Features","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}